TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV

Diseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap prote...

Full description

Saved in:
Bibliographic Details
Main Authors: Fulai Yu, Wei Xiang, Weiye Ou, Yang Li, Xinbiao Shu, Xiaoliang Li
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/12/1/25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587338761371648
author Fulai Yu
Wei Xiang
Weiye Ou
Yang Li
Xinbiao Shu
Xiaoliang Li
author_facet Fulai Yu
Wei Xiang
Weiye Ou
Yang Li
Xinbiao Shu
Xiaoliang Li
author_sort Fulai Yu
collection DOAJ
description Diseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap protein were mixed with the pattern recognition receptor (PRR) agonist FLICd as adjuvants and formulated with a micro-hydrogel adjuvant into PCV2 and PRV bivalent subunit vaccines. Twenty pigs, aged 30–35 days, were divided into groups A (received bivalent subunit vaccine) and B (received bivalent subunit vaccines with recombinant FLICd adjuvant), as well as C (non-vaccinated challenge control) and D (blank control). Groups A and B showed no significant difference in average daily weight gain compared to the unvaccinated controls. Fourteen days post-second vaccination, groups A and B exhibited significantly higher levels of PRV and PCV2 antibodies than groups C and D. Group B showed significantly higher average titers of PRV-specific neutralizing antibodies than group A. Fourteen days post-second vaccination, a PRV (ZJM-1 strain) challenge test was conducted. The vaccinated group achieved 100% protection. Vaccination effectively reduced virus load post-challenge and shortened the PRV shedding period. Vaccination with PCV2 and PRV bivalent subunit vaccines effectively prevents the onset of PCV2-related diseases and infections by wild pseudorabies strains.
format Article
id doaj-art-1be3e3d0918b4282904072f96caddc8f
institution Kabale University
issn 2306-7381
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj-art-1be3e3d0918b4282904072f96caddc8f2025-01-24T13:52:01ZengMDPI AGVeterinary Sciences2306-73812025-01-011212510.3390/vetsci12010025TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRVFulai Yu0Wei Xiang1Weiye Ou2Yang Li3Xinbiao Shu4Xiaoliang Li5Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaZhejiang MEBOLO Biotechnology Co., Ltd., Binhong West Road, Jinhua 321017, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, ChinaDiseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap protein were mixed with the pattern recognition receptor (PRR) agonist FLICd as adjuvants and formulated with a micro-hydrogel adjuvant into PCV2 and PRV bivalent subunit vaccines. Twenty pigs, aged 30–35 days, were divided into groups A (received bivalent subunit vaccine) and B (received bivalent subunit vaccines with recombinant FLICd adjuvant), as well as C (non-vaccinated challenge control) and D (blank control). Groups A and B showed no significant difference in average daily weight gain compared to the unvaccinated controls. Fourteen days post-second vaccination, groups A and B exhibited significantly higher levels of PRV and PCV2 antibodies than groups C and D. Group B showed significantly higher average titers of PRV-specific neutralizing antibodies than group A. Fourteen days post-second vaccination, a PRV (ZJM-1 strain) challenge test was conducted. The vaccinated group achieved 100% protection. Vaccination effectively reduced virus load post-challenge and shortened the PRV shedding period. Vaccination with PCV2 and PRV bivalent subunit vaccines effectively prevents the onset of PCV2-related diseases and infections by wild pseudorabies strains.https://www.mdpi.com/2306-7381/12/1/25PCV2PRVbivalent subunit vaccinepattern recognition receptors
spellingShingle Fulai Yu
Wei Xiang
Weiye Ou
Yang Li
Xinbiao Shu
Xiaoliang Li
TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
Veterinary Sciences
PCV2
PRV
bivalent subunit vaccine
pattern recognition receptors
title TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
title_full TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
title_fullStr TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
title_full_unstemmed TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
title_short TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
title_sort tlr agonist immunoadjuvants provide effective protection against pcv2 and prv infections in a bivalent subunit vaccine for pcv2 and prv
topic PCV2
PRV
bivalent subunit vaccine
pattern recognition receptors
url https://www.mdpi.com/2306-7381/12/1/25
work_keys_str_mv AT fulaiyu tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv
AT weixiang tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv
AT weiyeou tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv
AT yangli tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv
AT xinbiaoshu tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv
AT xiaoliangli tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv